Paid Clinical Trials Murfreesboro

Discover 1,257 paid clinical trials in Murfreesboro, Tennessee. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter

Filter results

Results: 1,257

Elacestrant, CombinationOpen-Label Umbrella Study To Evaluate Safety And Efficacy Of Elacestrant In Various Combination In Patients With Metastatic Breast Cancer

Recruiting

PHASE1

PHASE2

Sponsor:

Stemline Therapeutics, Inc.

Location:

Nashville TN, Cumming GA, Saint Louis MO, Dothan ALshow 37 more

Code:

NCT05563220

Conditions

Breast Cancer

Metastatic Breast Cancer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Elacestrant

Alpelisib

Everolimus

Ribociclib

Palbociclib

Observational StudyThe PEERLESS II Study

Recruiting

Sponsor:

Inari Medical

Location:

Brentwood TN, Nashville TN, Knoxville TN, Birmingham ALshow 45 more

Code:

NCT06055920

Conditions

Pulmonary Embolism

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

FlowTriever System

Anticoagulation Agents

RMC-6236Phase 3 Study of Daraxonrasib (RMC-6236) in Patients With Previously Treated Metastatic Pancreatic Ductal Adenocarcinoma (PDAC)

Recruiting

PHASE3

Sponsor:

Revolution Medicines, Inc.

Location:

Nashville TN, Saint Louis MO, Durham NC, Jacksonville FLshow 17 more

Code:

NCT06625320

Conditions

Pancreatic Cancer

PDAC

PDAC - Pancreatic Ductal Adenocarcinoma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

RMC-6236

Gemcitabine

nab-paclitaxel

Irinotecan

Liposomal irinotecan

N-acetylcysteineOral N-acetylcysteine for Retinitis Pigmentosa

Recruiting

PHASE3

Sponsor:

Johns Hopkins University

Location:

Nashville TN, Atlanta GA, Chicago IL, Evanston ILshow 21 more

Code:

NCT05537220

Conditions

Retinitis Pigmentosa

Eligibility Criteria

Sex: All

Age: 18 - 65

Healthy Volunteers: Not accepted

Interventions

N-acetylcysteine

Placebo

BemarituzumabA Study Evaluating Bemarituzumab in Solid Tumors With Fibroblast Growth Factor Receptor 2b (FGFR2b) Overexpression

Recruiting

PHASE1

PHASE2

Sponsor:

Amgen

Location:

Nashville TN, Indianapolis IN, Detroit MI, Tyler TXshow 9 more

Code:

NCT05325866

Conditions

Solid Tumors

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Bemarituzumab

Genetic TestingGenetic Testing to Select Therapy for the Treatment of Advanced or Metastatic Kidney Cancer, OPTIC RCC Study

Recruiting

PHASE2

Sponsor:

Vanderbilt-Ingram Cancer Center

Location:

Nashville TN, Cleveland OH, Dallas TX, Orange CAshow 1 more

Code:

NCT05361720

Conditions

Advanced Clear Cell Renal Cell Carcinoma

Metastatic Clear Cell Renal Cell Carcinoma

Stage III Renal Cell Cancer AJCC v8

Stage IV Renal Cell Cancer AJCC v8

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Cabozantinib

Ipilimumab

Nivolumab

HORIZANTAn Efficacy and Safety Evaluation of HORIZANT in Adolescents With Moderate-to-Severe Primary RLS

Recruiting

Sponsor:

XenoPort, Inc.

Location:

Nashville TN, Atlanta GA, Indianapolis IN, Saint Louis MOshow 8 more

Code:

NCT02560766

Conditions

RLS

Eligibility Criteria

Sex: All

Age: 13 - 17

Healthy Volunteers: Not accepted

Interventions

HORIZANT 300 mg

HORIZANT 600 mg

Placebo

Observational StudyNOC2 Spine Registry

Recruiting

Sponsor:

DC2 Healthcare

Location:

Nashville TN

Code:

NCT02187666

Conditions

Spinal Disease

Eligibility Criteria

Sex: All

Age: 0 - 70+

Healthy Volunteers: Not accepted

Radiation TherapyRegistry Study for Radiation Therapy Outcomes

Recruiting

Sponsor:

Proton Collaborative Group

Location:

Franklin TN, Knoxville TN, Atlanta GA, Cincinnati OHshow 19 more

Code:

NCT01255748

Conditions

Neoplasms

Eligibility Criteria

Sex: All

Age: 0 - 70+

Healthy Volunteers: Not accepted

Interventions

Proton Therapy, Photon Therapy, SRS, Brachytherapy

APG777A Study Evaluating APG777 in Atopic Dermatitis

Recruiting

PHASE2

Sponsor:

Apogee Therapeutics, Inc.

Location:

Nashville TN, Bowling Green KY, Douglasville GA, Mason OHshow 33 more

Code:

NCT06395948

Conditions

Atopic Dermatitis

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

APG777

Placebo